ArticleNutrition journal2026
Associations between carotenoids and rheumatoid arthritis risk: evidence from two population-based studies.
Article in Nutrition journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundCarotenoids are common natural anti-inflammatory antioxidants produced by plants and some microorganisms. However, there are limited reports on the association between carotenoids and risk of rheumatoid arthritis (RA).
methodsWe analyzed data of participants from the National Health and Nutrition Examination Survey (NHANES) and UK Biobank (UKB). In the NHANES, a total of 40,410 and 13,440 participants were included to evaluate the association of dietary carotenoid intake and serum carotenoid levels with RA, respectively. Among 179,171 participants in the UKB, 2,156 individuals developed RA over a median follow-up of 7.74 years. A weighted multivariable logistic regression model and quantile G-Computation (QGC) model were established to investigate single and joint effect of carotenoid levels (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein and zeaxanthin) on RA in NHANES by cross-sectional study design. Furthermore, Cox proportional hazards regression model was used to validate the potential association in UKB cohort, and restricted cubic spline (RCS) regression was applied to estimate the possible nonlinear association.
resultsCompared to the lowest quartile (Q1), dietary intake level of alpha-carotene in Q3 were consistently associated with a decreased risk of RA in NHANES (odds ratio [OR]: 0.771, 95% confidence interval [CI]: 0.628 to 0.946, P-value = 0.013) and UKB (hazards ratio [HR]: 0.875, 95% CI: 0.775 to 0.987, P-value = 0.030). At serum level, all kinds of carotenoids in Q4 were significantly inversely associated with RA when compared with Q1. In QGC model, each one-quartile increase in the intake (OR: 0.886, 95% CI: 0.841 to 0.933, P-value < 0.001) or serum levels (OR: 0.795, 95% CI: 0.732 to 0.864, P-value < 0.001) of the six carotenoids showed a negative correlation against of RA in NHANES. RCS analysis indicated that dietary intake of total-carotene (P-value = 0.0020 for nonlinear), alpha-carotene (P-value = 0.0175 for nonlinear), and beta-carotene (P-value = 0.0021 for nonlinear) exhibited a nonlinear relationship with the risk of RA in UKB. The protective effects against RA were found within the ranges of log natural transformation for total-carotene (5.28 to 8.69 µg/day), and beta-carotene (5.18 to 8.61 µg/day).
conclusionBoth cross-sectional and prospective studies indicate that carotenoids, as natural and effective anti-inflammatory antioxidants, were negatively associated with RA. Daily intake of an appropriate dose can significantly reduce the risk of RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.